Viridian Therapeutics, Inc.\DE
VRDNUnited States
49 filed reports · 516 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
49 reports · Jun 2014 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 37 | 4,515 | Jun 2014 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 12 | 3,765 | Dec 2014 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 282 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 5, 2026 | 147 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 671 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 192 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 131 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 127 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 3, 2025 | 372 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 12, 2024 | 149 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 128 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 8, 2024 | 123 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 27, 2024 | 321 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 13, 2023 | 133 | Open |
Financial data
516 concepts · 8,280 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial509 concepts · 8,096 facts · Dec 2012 to Aug 2026
- Depreciation depletion and amortization66 · Jun 2013 to Jun 2026
- Net income loss66 · Jun 2013 to Jun 2026
- Operating expenses (US GAAP)66 · Jun 2013 to Jun 2026
- Operating income loss66 · Jun 2013 to Jun 2026
- Revenue66 · Jun 2013 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets65 · Sep 2013 to Jun 2026
- Net cash provided by used in financing activities65 · Sep 2013 to Jun 2026
- Net cash provided by used in operating activities65 · Sep 2013 to Jun 2026
- Accounts payable current63 · Dec 2013 to Jun 2026
- Assets63 · Dec 2013 to Jun 2026
- Assets current63 · Dec 2013 to Jun 2026
- Common stock par or stated value per share63 · Dec 2013 to Jun 2026
- Common stock shares authorized63 · Dec 2013 to Jun 2026
- Common stock shares issued63 · Dec 2013 to Jun 2026
- Common stock shares outstanding63 · Dec 2013 to Jun 2026
- Employee related liabilities current63 · Dec 2013 to Jun 2026
- Liabilities current63 · Dec 2013 to Jun 2026
- Net cash provided by used in investing activities63 · Sep 2013 to Jun 2026
- Other accrued liabilities current63 · Dec 2013 to Jun 2026
- Prepaid expense and other assets current63 · Dec 2013 to Jun 2026
- Property plant and equipment net63 · Dec 2013 to Jun 2026
- General and administrative expense (US GAAP)62 · Jun 2013 to Sep 2025
- Liabilities and stockholders equity62 · Dec 2013 to Jun 2026
- Payments to acquire property plant and equipment62 · Dec 2013 to Jun 2026
Product1 concepts · 103 facts · Jun 2017 to Jun 2026
- Revenue103 · Jun 2017 to Jun 2026
Segment6 concepts · 81 facts · Dec 2022 to Jun 2026
- Allocated share based compensation expense14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Operating expenses (US GAAP)14 · Dec 2022 to Jun 2026
- Reportable Segment14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Revenue11 · Dec 2023 to Jun 2026
Segments
184 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service7 members · 103 facts
- Collaboration Revenue24 · Jun 2017 to Dec 2021
- Grant24 · Jun 2017 to Dec 2021
- Reimbursement Revenue16 · Jun 2017 to Dec 2020
- Milestone Payments13 · Sep 2017 to Dec 2019
- Collaboration11 · Dec 2023 to Jun 2026
- License11 · Dec 2023 to Jun 2026
- Collaboration Revenue Related Party4 · Mar 2020 to Jun 2021
Statement business segments1 member · 81 facts
- Reportable81 · Dec 2022 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.